Literature DB >> 16962213

Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia.

Francesco Panza1, Cristiano Capurso, Alessia D'Introno, Anna M Colacicco, Antonio Capurso, Vincenzo Solfrizzi.   

Abstract

Mild cognitive impairment (MCI) is thought to be a prodromal phase of Alzheimer's disease, but in population-based studies MCI classification is less consistent than in clinical series, suggesting that MCI is a heterogeneous descriptor and the outcome at follow-up depends on which population is studied and how MCI is defined. We discussed in the present paper the issue of the heterogeneity of MCI and other predementia syndromes, both in clinical presentation and progression to dementia, supported by the findings of the Italian Longitudinal Study on Aging (ILSA) and other population-based and clinical-based studies.

Entities:  

Mesh:

Year:  2006        PMID: 16962213     DOI: 10.1016/j.neurobiolaging.2006.07.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.

Authors:  Kristen L Sager; Joanne Wuu; Susan E Leurgans; Howard D Rees; Marla Gearing; Elliott J Mufson; Allan I Levey; James J Lah
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

2.  Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings.

Authors:  G A Jicha; E Abner; F A Schmitt; G E Cooper; N Stiles; R Hamon; S Carr; C D Smith; W R Markesbery
Journal:  Dement Geriatr Cogn Disord       Date:  2008-08-23       Impact factor: 2.959

3.  Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.

Authors:  G A Jicha; F A Schmitt; E Abner; P T Nelson; G E Cooper; C D Smith; W R Markesbery
Journal:  Neurobiol Aging       Date:  2008-11-20       Impact factor: 4.673

4.  Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study.

Authors:  Ana Luisa Sosa; Emiliano Albanese; Blossom C M Stephan; Michael Dewey; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Ivonne Z Jiménez-Velázquez; Juan J Llibre Rodriguez; Aquiles Salas; Joseph Williams; Isaac Acosta; Maribella González-Viruet; Milagros A Guerra Hernandez; Li Shuran; Martin J Prince; Robert Stewart
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

Review 5.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

6.  Association between cognitive function and ambient particulate matters in middle-aged and elderly Chinese adults: Evidence from the China Health and Retirement Longitudinal Study (CHARLS).

Authors:  Yifan Yao; Kai Wang; Hao Xiang
Journal:  Sci Total Environ       Date:  2022-03-11       Impact factor: 10.753

7.  Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.

Authors:  Blossom Christa Maree Stephan; Thais Minett; Emma Pagett; Mario Siervo; Carol Brayne; Ian G McKeith
Journal:  BMJ Open       Date:  2013-02-04       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.